供研究使用的人體生物類似抗體

來源：發(fā)布時(shí)間：2025-03-19

Leinco Technologies offers high-purity research-grade biosimilar antibodies with the same specifications as many therapeutic antibodies. Therapeutic antibodies are widely used for the treatment of diseases, including cancer and autoimmunity.

The Problem? Therapeutic-grade biologics are expensive, challenging to source, and only available in large quantities, making studies using these antibodies cost prohibited.

The Solution? Research-grade biosimilar antibodies are produced by recombinant technology using the variable region sequences of therapeutic antibodies, resulting in the same specificities as approved biologics. Leinco's recombinant biosimilar antibodies are ideal research tools as they are fast, inexpensive, manufactured in an animal free facility and formulated in sterile PBS buffer, free of additives or preservatives.

Biosimilars Specifications1,、Purity > 95% by SDS-PAGE and ≥ 98% monomer by analytical SEC2,、Endotoxin ≤ 0.5 EU/mg as determined by the LAL method3、Manufactured in an animal-free facility using protein-free, animal-origin-free cell culture media 4、Ultra-low levels of leached protein A5,、Sterile filtered and formulated in Leinco's in vivo grade PBS pH 7.2 containing no K or Ca, additives, preservatives, or carrier proteins6,、Many research applications, includingFC, ELISA, IHC, FA, PK and potencyassays 7、Pathogen tested (IMPACT1)